Prof. Frimpong-Manso Opuni appointed Acting CEO of FDA

Professor Kwabena Frimpong-Manso Opuni has been appointed as the new Acting Chief Executive  (CEO) of the Food and Drugs Authority (FDA), effective Monday, July 14, 2025.

The Authority announced his appointment in a brief statement shared on its social media handles.

Prof. Opuni takes over from Dr. Delese Mimi Darko, who has served as CEO since 2017.

It will be recalled that Dr. Darko was recently appointed as the Director-General of the Africa Medicines Agency (AMA), marking a significant milestone in her distinguished career in public health leadership.

Before his new role, Prof. Opuni served as the Board Chairman of the FDA, bringing with him extensive experience in public health policy, regulatory oversight, and institutional governance.

In a statement, the FDA extended its warmest congratulations to Prof. Opuni and expressed confidence in his ability to lead the Authority in fulfilling its mandate of safeguarding public health and safety.